Proto Labs, Inc.
NYSE:PRLBManufacturing - Miscellaneous
+$1.44 today
- Market cap
- $1.53B
- Beta
- 1.39
- P/E (TTM)
- 75.0
- EPS (TTM)
- $1.08
Volume 0.23M
Average 0.18M
PRLB Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Proto Labs, Inc.NYSE: PRLB
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables growth accelerates
Q2 FY2026 accounts receivables of $9.54M (cash outflow) rose 3777.6% year over year, ahead of the -5699.2% change in trailing-twelve-month accounts receivables. Sequentially, it rose 39.1% from the prior quarter. Over 3 fiscal years it compounded at +128.3% a year.
Context
- Accounts receivables amounted to 2.3% of revenue in FY2025, up 0.6 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +3777.6% holds above the trailing-twelve-month pace of -5699.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (12.48M) USD
- Year-over-year change
- -239.3%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (12.48M) | -239.3% |
| FY2024 | 2024-12-31 | 8.96M | +96.9% |
| FY2023 | 2023-12-31 | 4.55M | +533.7% |
| FY2022 | 2022-12-31 | (1.05M) | +95.0% |
| FY2021 | 2021-12-31 | (20.89M) | — |
Accounts Receivables vs competitors
How PRLB compares with its peers on the latest reported figures
- PRLB's LTM Jun 2026 accounts receivables of $20.72M is the 6th largest of the 10 companies compared; the peer median is $63K.
- Its year-over-year change of -5699.2% is the lowest of 9, against a peer median of +159.7%.
- Accounts receivables amounts to 3.7% of revenue for PRLB, versus a peer median of 2.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $85.2M | +373.1% | -67.3% | 2.9% | |
| LTM Apr 2026 | $61.61M | +428.4% | +46.9% | 8.0% | |
| LTM Mar 2026 | $39.4M | -364.4% | — | 1.4% | |
| LTM Feb 2026 | $37.71M | +4409.1% | — | 5.9% | |
| LTM Apr 2026 | $24.5M | -56.6% | — | 2.7% | |
| LTM Jun 2026 | $20.72M | -5699.2% | +128.3% | 3.7% | |
RHLDResolute Holdings Management, Inc. | LTM Mar 2026 | $17.27M | +190.5% | — | 2.3% |
| LTM Sep 2026 | $13.29M | +129.0% | — | 0.9% | |
CCECCapital Clean Energy Carriers Corp. | FY2025 | $3.62M | — | — | 1.8% |
EVEXEve Holding, Inc. | LTM Mar 2026 | $63K | -96.5% | +24.5% | — |
| Peer median (excluding PRLB) | $63K | +159.7% | +24.5% | 2.5% | |
Competitors are the stored peer set for PRLB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 33.37M | (103.46M) | 17.22M | 16.59M | 21.24M |
| Depreciation & Amortization | 40.49M | 39.43M | 37.53M | 35.81M | 33.81M |
| Deferred Income Tax | 339K | (9.5M) | (7.66M) | (5.15M) | 2.91M |
| Stock-Based Compensation | 19.1M | 17.55M | 15.99M | 17M | 15.73M |
| Change in Working Capital | (25.64M) | (1.6M) | 5.58M | 10.97M | 567K |
| Accounts Receivables | (20.89M) | (1.05M) | 4.55M | 8.96M | (12.48M) |
| Inventory | (2.39M) | (310K) | 112K | 1.26M | (2.11M) |
| Accounts Payables | 4.65M | 1.38M | (1.84M) | 480K | (333K) |
| Other Working Capital | (7.02M) | (1.62M) | 2.75M | 275K | 15.49M |
| Other Non-Cash Items | (12.41M) | 119.67M | 4.62M | 2.61M | 241K |
| Operating Cash Flow | 55.24M | 62.08M | 73.27M | 77.83M | 74.5M |
| Capital Expenditures | (34.21M) | (21.69M) | (28.12M) | (9.17M) | (14.84M) |
| Acquisitions (Net) | (127.41M) | 0 | 0 | 0 | 834K |
| Purchases of Investments | (16.16M) | (46.87M) | 0 | (25.07M) | (17.02M) |
| Sales of Investments | 83.12M | 21.36M | 23.87M | 20.63M | 17.61M |
| Other Investing Activities | 0 | 4.11M | (301K) | 34K | 0 |
| Investing Cash Flow | (94.66M) | (43.09M) | (4.55M) | (13.58M) | (13.41M) |
| Debt Repayment | (552K) | (531K) | (306K) | (296K) | (309K) |
| Common Stock Issued | 5.86M | 3.95M | 3.84M | 4.02M | 6.34M |
| Common Stock Repurchased | (23.28M) | (29.66M) | (43.95M) | (60.28M) | (42.96M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.23M) | (1.68M) | (1.44M) | (2M) | (3.43M) |
| Financing Cash Flow | (22.2M) | (27.92M) | (41.86M) | (58.55M) | (40.37M) |
| Effect of Forex Changes | (54K) | (436K) | 368K | (418K) | 1.03M |
| Net Change in Cash | (61.67M) | (9.37M) | 27.23M | 5.28M | 21.76M |
| Free Cash Flow | 21.03M | 40.39M | 45.16M | 68.66M | 59.66M |
Proto Labs, Inc.
NYSE:PRLB
Intrinsic Alpha fair value
Locked
Current Price
$63.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.